Global Bioinformatics Partnering Terms and Agreements: Featuring Key Trends, Players and Deals From 2015-2022

2022-07-06
PRNewswire
放射疗法AHA会议
DUBLIN, July 6, 2022 /PRNewswire/ -- The "Global Bioinformatics Partnering Terms and Agreements 2015 to 2022" report has been added to
ResearchAndMarkets.com's offering.
The Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in bioinformatics partnering deals
Partnering agreement structure
Partnering contract documents
Top deals by value
Most active deal makers
Financial deal terms for bioinformatics
The Global Bioinformatics Partnering Terms and Agreements 2015 to 2022 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors bioinformatics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.
Bioinformatics deals have increased in terms of popularity for partnering in the past decade, as computing power has been embraced in order to speed up the discovery, evaluation and clinical assessment processes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all bioinformatics partnering deals announced since January 2015, including financial terms where available, including over 1600 links to online deal records of actual bioinformatics partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in bioinformatics dealmaking
2.1. Introduction
2.2. Bioinformatics partnering over the years
2.3. Most active bioinformatics dealmakers
2.4. Bioinformatics partnering by deal type
2.5. Bioinformatics partnering by therapy area
2.6. Deal terms for bioinformatics partnering
2.6.1 Bioinformatics partnering headline values
2.6.2 Bioinformatics deal upfront payments
2.6.3 Bioinformatics deal milestone payments
2.6.4 Bioinformatics royalty rates
Chapter 3 - Leading bioinformatics deals
3.1. Introduction
3.2. Top bioinformatics deals by value
Chapter 4 - Most active bioinformatics dealmakers
4.1. Introduction
4.2. Most active bioinformatics dealmakers
4.3. Most active bioinformatics partnering company profiles
Chapter 5 - Bioinformatics contracts dealmaking directory
5.1. Introduction
5.2. Bioinformatics contracts dealmaking directory
Chapter 6 - Bioinformatics dealmaking by technology type
Companies Mentioned
1QBit
2bPrecise
3M
111
121nexus
A3 Informatics
Abarca
Abramson Cancer Center
Abyde
Academic Medical Center
Accelq
AccuWeather
Acentrus Specialty
ActX
Acuant
Acurian
Adaptiiv
ADAS 3D Medical
Adents
Adracare
Advaita
Advarra
Advocate Health Care
Aether
Aetion
Aetos Pharma
Aevolve
Agadia Systems
AgileBio
AiCure
Aidoc
Akerna
Alibaba Health
Alienware
Alit Life Science
Allergan
Alliance for Clinical Research Excellence and Safety (ACRES)
Alliance For Clinical Trials In Oncology
Allosteric Bioscience
Allotrope Foundation
AllyAlign Health
Almirall
AltMed Florida
Alvarado Hospital Medical Center
Alyvant
Alzheimer's Drug Discovery Foundation
Amazon Web Services
American Academy of Neurology
American Diabetes Association
American Heart Association
American Medical Association
American Sleep Apnea Association
American Society of Hematology
American Speech-Language-Hearing Association
American Well
Amerinet
Amplifire
AMRA
Amyris
Ancestry
Andrew Alliance
Anelto
Annum Health
Anthem
Apollo Health
AppBus
Appistry
Applied BioMath
Applied DNA Sciences
Appriss Health
Apricity Health
Arc Bio
ArcherDX
ArisGlobal
Arivis
Arm
Armor
Arria
Artificial
Athenahealth
ATMPS
Audaire Health
Auria Biobank
Aurochs
Autolomous
Auxita
For more information about this report visit https://www.researchandmarkets.com/r/aajezq
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。